Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|February 22, 2019
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid LiposarcomaMarcel Trautmann, Magdalene Cyra, Ilka Isfort, et al.
BMC Complementary Medicine and Therapies|November 24, 2021
Complementary medicine in Germany: a multi-centre cross-sectional survey on the usage by and the needs of patients hospitalized in university medical centersAnn-Kathrin Lederer, Alexandra Baginski, Lena Raab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid LiposarcomaMarcel Trautmann, Jasmin Menzel, Christian Bertling, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 22, 2018
Boosting Antitumor Drug Efficacy with Chemically Engineered Multidomain ProteinsSeah Ling Kuan, Stephan Fischer, Susanne Hafner, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 13, 2022
SS18-SSX drives CREB activation in synovial sarcomaMagdalene Cyra, Miriam Schulte, Ruth Berthold, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2019
SS18-SSX-Dependent YAP/TAZ Signaling in Synovial SarcomaIlka Isfort, Magdalene Cyra, Sandra Elges, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2022
Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement ActivationMarkus Anliker, Daniela Drees, Lorin Loacker, et al.
Blood Advances|July 10, 2023
Complement and platelets: prothrombotic cell activation requires membrane attack complex-induced release of danger signalsMarco Mannes, Veronika Pechtl, Susanne Hafner, et al.
Stem Cell Research|September 16, 2016
Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemnessLukas Perkhofer, Karolin Walter, Ivan G Costa, et al.
Pageof 4